Shanghai Allist Pharmaceuticals Co. Ltd. A (688578) — Cash Flow Quality Index
Shanghai Allist Pharmaceuticals Co. Ltd. A (688578) has a Cash Flow Quality Index of 1.19x as of September 2025. Operating cash flow of CN¥670.83 Million exceeds net income of CN¥564.54 Million, indicating high earnings quality where cash backs reported profits. Also explore 688578 total asset value for the complete picture of this company's asset base.
Cash Flow Quality Index
Operating Cash Flow
Net Income
Data as of
Shanghai Allist Pharmaceuticals Co. Ltd. A Cash Flow Quality Index (2021–2025)
Historical Cash Flow Quality Index for Shanghai Allist Pharmaceuticals Co. Ltd. A across 5 annual periods. Values consistently above 1.0x indicate high-quality earnings. Check tangible equity quality of Shanghai Allist Pharmaceuticals Co. Ltd. to evaluate the tangible quality of the company's equity base.
Annual Cash Flow Quality Index for Shanghai Allist Pharmaceuticals Co. Ltd. A (2021–2025)
Year-by-year earnings quality comparison for Shanghai Allist Pharmaceuticals Co. Ltd. A. For live market cap and the full company financial profile, see market cap of Shanghai Allist Pharmaceuticals Co. Ltd..
| Year | Quality Index | Operating CF (CNY) | Net Income | YoY Change |
|---|---|---|---|---|
| 2025 | 1.06x | CN¥2.32 Billion | CN¥2.18 Billion | ▼ -2.8% |
| 2024 | 1.10x | CN¥1.57 Billion | CN¥1.43 Billion | ▲ +4.6% |
| 2023 | 1.05x | CN¥674.65 Million | CN¥644.17 Million | ▲ +49.2% |
| 2022 | 0.70x | CN¥91.63 Million | CN¥130.52 Million | ▼ -56.2% |
| 2021 | 1.60x | CN¥29.29 Million | CN¥18.27 Million | — |